摘要
目的:研究逍遥散对产后抑郁大鼠海马中单胺类神经递质含量的影响。方法:将48只卵巢切除的雌性大鼠分为4组:对照组,模型组,氟西汀组(阳性对照组)和逍遥散组。前23 d,除对照组外,其余大鼠每天皮下注射雌激素模拟大鼠的怀孕状态;接下来的30 d,各组大鼠分别灌胃给予受试物。实验结束后,观察大鼠的行为学指标;取出海马组织,用酶联免疫法测定海马组织中单胺类神经递质去甲肾上腺素(noradrenaline,NE)、多巴胺(dopamine,DA)、5-羟色胺(5-hydroxytryptamine,5-HT)和5-羟吲哚乙酸(5-hydroxyindoleacetic acid,5-HIAA)的含量。结果:与对照组相比,模型组行为学表现明显处于产后抑郁状态,海马中5-HT、NE和DA显著降低(P<0.01),5-HIAA显著增加(P<0.01);而中药逍遥散可显著改善行为学指标,并增加海马组织中5-HT、NE和DA的含量,降低5-HIAA的含量(P<0.01)。逍遥散的效果与氟西汀类似。结论:逍遥散可显著调节大鼠海马中单胺类神经递质的含量,发挥抗抑郁作用。
Objective: To investigate the effects of Xiaoyao Powder,a compound traditional Chinese herbal medicine for treatment of depression,on monoamine neurotransmitters in hippocampus of rats with postpartum depression(PPD).Methods: Ovariectomized Sprague-Dawley rats were randomly divided into 4 groups: control group,untreated group,fluoxetine hydrochloride group and Xiaoyao Powder group.Except for the control group,the rats in the other 3 groups were injected subcutaneously with estrogen for 23 successive days to induce the "pregnancy" state.In the next 30 successive days,rats were given test drugs respectively and the concentrations of noradrenaline(NE),dopamine(DA),5-hydroxytryptamine(5-HT) and 5-hydroxyindoleacetic acid(5-HIAA) in hippocampus were measured by enzyme-linked immunosorbent assay(ELISA).Results: PPD was induced in rats of untreated group,and compared with rats of control group,the concentrations of NE,DA and 5-HT in the hippocampus significantly reduced(P0.01),while the concentration of 5-HIAA significantly increased(P0.01).Xiaoyao Powder treatment significantly improved the behavior indexes and levels of monoamine neurotransmitters in hippocampus(P0.01).Xiaoyao Powder and fluoxetine hydrochloride produced similar effects in rats with PPD.Conclusion: Xiaoyao Powder produces an antidepression effect in rats by regulating the levels of monoamine neurotransmitters in hippocampus.
出处
《中西医结合学报》
CAS
2010年第11期1075-1079,共5页
Journal of Chinese Integrative Medicine
基金
国家自然科学基金资助项目(No.30572339)
关键词
逍遥散
抑郁症
产后
神经行为学表现
神经递质药
Xiaoyao Powders depression postpartum neurobehavioral manifestations neurotransmitter agents